Skip to main content
Equibles

STATE STREET CORP

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 93751 BOSTON, MA
Back to TSHA Full portfolio

Position in TSHA

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$77,783,275
+$27,678,697 QoQ
Shares Held
11,421,920
+1.9% QoQ
Ownership
3.51%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 208 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 12% Shared 0% None 88%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. TSHA ranks #90 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in TSHA

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $77,783,275 11,421,920
2026-03-31 $50,104,578 11,209,078
2025-12-31 $59,345,462 10,790,084
2025-09-30 $23,663,240 7,236,465
2025-06-30 $11,869,496 5,138,310
2025-03-31 $4,494,581 3,233,512
2024-12-31 $11,200,654 6,474,367
2024-09-30 $6,972,826 3,469,068
2024-06-30 $7,433,263 3,318,421
2024-03-31 $974,422 339,520
2023-12-31 $253,499 143,220
2023-09-30 $442,463 140,020
2023-06-30 $75,962 114,920
2023-03-31 $91,706 114,920
2022-12-31 $259,719 114,920
2022-09-30 $149,420 77,420
2022-06-30 $288,002 77,420
2022-03-31 $3,254,875 499,214
2021-12-31 $5,407,568 464,169
2021-09-30 $6,557,703 352,186
2021-06-30 $6,754,722 318,619
2021-03-31 $2,479,462 122,141
2020-12-31 $2,922,213 110,106